ALERT!

This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Long-term forecasting and comparison of mortality in the Evaluation of the Xience Everolimus Eluting Stent vs. Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization (EXCEL) trial: prospective validation of the SYNTAX Score II

Tuesday, January 20, 2015

Submitted by

Ruben Osnabrugge

Source

Source Name: European Heart Journal

Source URL: http://www.ncbi.nlm.nih.gov/pubmed/25583761

Author(s)

Campos CM, van Klaveren D, Farooq V, Simonton CA, Kappetein AP, Sabik JF 3rd, Steyerberg EW, Stone GW, Serruys PW; On Behalf of the EXCEL Trial Investigators.

The investigators of this project aimed to validate the SYNTAX Score II. This is a risk prediction tool that combines clinical characteristics and the original anatomical SYNTAX score in order to make 4 year mortality predictions with PCI or CABG in patients with unprotected left main disease (ULMCA) and an original SYNTAX score <33). They found that the SYNTAX Score II predicts an equipoise for long-term mortality between CABG and PCI in these patients.